[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"human-papilloma-virus-related-cervical-carcinoma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:human-papilloma-virus-related-cervical-carcinoma":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100578395","the-womens-screening-and-self-testing-program-prometa-study-100578395",false,"NCT06810739","The Women's Screening and Self-Testing Program (PROMETA) Study","A Hybrid Type III Effectiveness - Implementation, Pragmatic Intervention Trial for Cervical Cancer Screen and Treat in Mozambique","PROMETA","Inclusion Criteria:\n\n* Women 25-49 years\n* Accessing HIV care and treatment services\n* Not being pregnant\n* Patients with a cervix\n\nExclusion Criteria:\n\n* Physical or mental impairment that inhibits participation in the study\n* Pregnant women or \\\u003C6 weeks post-partum\n* Women who have undergone a total hysterectomy with removal of the cervix","FEMALE","25 Years","49 Years",{"count":21,"type":22},8445,"ESTIMATED","INTERVENTIONAL",[25],"NA","This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-positive women undergoing treatment. Secondary outcomes will focus on other implementation outcomes, and if successful, will be utilized to inform future research to take this approach to scale across Mozambique.",[28],"Human Papilloma Virus Related Cervical Carcinoma",[30,31,32,33,34],"Human Immunodeficiency Virus","Self swab","Mozambique","Cervical cancer","Implementation science","NOT_YET_RECRUITING","2025-12-12",{"date":38,"type":39},"2025-12-17","ACTUAL",{"date":41,"type":22},"2026-01-01",{"date":43,"type":22},"2028-08-31",{"name":45,"class":46},"Tulane University","OTHER","Human Papilloma Virus-Related Cervical Carcinoma"]